eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
1/2019
vol. 11
 
Share:
Share:
more
 
 
abstract:
Original paper

Itopride as an element of the management of opioid-induced constipation – preliminary results of an observational study

Tomasz Dzierżanowski, Aleksandra Ciałkowska-Rysz

Medycyna Paliatywna 2019; 11(1): 27–32
Online publish date: 2019/03/25
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
It is recommended that laxatives be prescribed for the prevention of opioid-induced constipation (OIC). This retrospective study aims to verify whether itopride, added to preventive OIC therapy, decreases the necessity of regular laxatives in the prevention of opioid-induced constipation in adult palliative care patients. Ninety-two patients met the inclusion criteria. All patients received, if needed, regular laxatives, oxycodone/naloxone (OXN), itopride 50 mg TID orally, or a combination of these drugs. All methods were similarly effective in the prevention of OIC. However, the necessity of laxatives decreased in groups where itopride was used, compared to control or OXN groups (p = 0.009). OXN did not decrease laxative use (p = 0.22). We conclude that adding itopride, but not oxycodone/naloxone, resulted in a decrease in the necessity of laxative use in the prevention of OIC. Taking into consideration the limitations of this study, a randomised controlled trial is necessary to confirm this finding.
keywords:

palliative care, constipation, prokinetics, itopride, oxycodone/naloxone

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe